Page 28 - Molecular features of low-grade developmental brain tumours
P. 28
1
26
CHAPTER 1
74. Curatolo, P., Moavero, R. & de Vries, P. J. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 14, 733-745, doi:10.1016/S1474-4422(15)00069-1 (2015).
75. Leclezio, L., Jansen, A., Whittemore, V. H. & de Vries, P. J. Pilot validation of the tuberous sclerosis- associated neuropsychiatric disorders (TAND) checklist. Pediatr Neurol 52, 16-24, doi:10.1016/j. pediatrneurol.2014.10.006 (2015).
76. Crino, P. B., Nathanson, K. L. & Henske, E. P. The tuberous sclerosis complex. N Engl J Med 355, 1345-1356, doi:10.1056/NEJMra055323 (2006).
77. Roth, J. et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 49, 439-444, doi:10.1016/j.pediatrneurol.2013.08.017 (2013).
78. Mizuguchi, M. & Takashima, S. Neuropathology of tuberous sclerosis. Brain Dev 23, 508-515, doi:10.1016/s0387-7604(01)00304-7 (2001).
79. Aronica, E. & Crino, P. B. Epilepsy related to developmental tumors and malformations of cortical development. Neurotherapeutics 11, 251-268, doi:10.1007/s13311-013-0251-0 (2014).
80. Muhlebner, A. et al. Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex. PLoS One 11, e0157396, doi:10.1371/journal.pone.0157396 (2016).
81. Aronica, E. & Muhlebner, A. Neuropathology of epilepsy. Handb Clin Neurol 145, 193-216, doi:10.1016/B978-0-12-802395-2.00015-8 (2017).
82. Cotter, J. A. An update on the central nervous system manifestations of tuberous sclerosis complex. Acta Neuropathol 139, 613-624, doi:10.1007/s00401-019-02003-1 (2020).
83. Boer, K. et al. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology 28, 577-590, doi:10.1111/j.1440-1789.2008.00920.x (2008).
84. Grajkowska, W., Kotulska, K., Jurkiewicz, E. & Matyja, E. Brain lesions in tuberous sclerosis complex.
Review. Folia Neuropathol 48, 139-149 (2010).
85. Zurolo, E. et al. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of
cortical development. Brain 134, 1015-1032, doi:10.1093/brain/awr032 (2011).
86. Aronica, E., Becker, A. J. & Spreafico, R. Malformations of cortical development. Brain Pathol 22, 380-
401, doi:10.1111/j.1750-3639.2012.00581.x (2012).
87. Crino, P. B., Trojanowski, J. Q., Dichter, M. A. & Eberwine, J. Embryonic neuronal markers in tuberous
sclerosis: single-cell molecular pathology. Proc Natl Acad Sci U S A 93, 14152-14157, doi:10.1073/
pnas.93.24.14152 (1996).
88. Lee, A. et al. Markers of cellular proliferation are expressed in cortical tubers. Ann Neurol 53, 668-
673, doi:10.1002/ana.10579 (2003).
89. Talos, D. M., Kwiatkowski, D. J., Cordero, K., Black, P. M. & Jensen, F. E. Cell-specific alterations of
glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 63, 454-
465, doi:10.1002/ana.21342 (2008).
90. Boer, K. et al. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Epilepsia 50, 2629-2637, doi:10.1111/j.1528-1167.2009.02191.x (2009).
91. Orlova, K. A. & Crino, P. B. The tuberous sclerosis complex. Ann N Y Acad Sci 1184, 87-105,
doi:10.1111/j.1749-6632.2009.05117.x (2010).
92. Muhlebner, A. et al. Specific pattern of maturation and differentiation in the formation of cortical
tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression. J
Neurodev Disord 8, 9, doi:10.1186/s11689-016-9142-0 (2016).
93. Park, S. H. et al. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta
